Within this risk analysis the GMP relevant risks of the equipment are recorded. This risk analysis does not have any reference or effects to the safety relevant risk analysis according to the Machine Guidelines.
Following the baseline „Pharmaceutical Engineering Guides for New and Renovate Facilities Vol. 5 Commissioning and Qualification” (ISPE 2001) the risk examination is carried out in two levels.
In the first level (please see Appendix "GMP Risk Analysis - Risk Evaluation") possible risks are established that could occur to the product considering process steps and equipment parts. Based on the risk assessment a risk evaluation code (RWD) is determined for each risk (see section 4 for computation of RWD).
If the RWD is smaller than or equal to 12 and no category assessed with "4" it is not necessary to follow the risk any longer. This decision is additionally explained verbally.
If a risk is not followed any further it must be guaranteed that other equipment functionalities reliably realise the risk's appearance.
The functions used for the protection of those risks not followed any further are considered in both parts of the risk analysis.
If category R (risk for the product) is assessed with „4“ in the first part and RWD 16 the possible fault is classified as „ GMP Critical“ and will be marked „G“ in the corresponding column.
In the second level (please see Appendix "GMP Risk Analysis - Risk Evaluation") corrective and preventive actions for the risks to be followed are prescribed. Based on these actions the RWD value will be assigned again.
All risks are considered operative risks, which cannot be evaluated by KORSCH AG. These are, for example, litigation risks and systemic risks. Operational risks must be considered by the operator of the machine / plant.